期刊文献+

周疗在宫颈癌同步放化疗中的作用 被引量:5

The efficient of chemotherapy weekly in the chemoradiotherapy of cervical cancer
下载PDF
导出
摘要 目的评价周疗在宫颈鳞癌同步放化疗中的作用。方法对该院2003年1月至2007年10月收治的Ⅲb期宫颈鳞癌168例分为两组,其中观察组86例采用紫杉醇+顺铂周疗+同步放疗,对照组82例采用紫杉醇+顺铂3周疗法+同步放疗,比较两组的5年生存率和不良反应。结果观察组5年生存率为52.3%(45/86),对照组为42.7%(35/82),两组比较差异无统计学意义(P>0.05);观察组有效率(CR+PR)为94.2%(81/86),对照组为92.7%(76/82),两组比较差异无统计学意义(P>0.05);观察组Ⅲ度以上骨髓抑制发生率为9.3%(8/86),对照组为20.7%(17/82),两组比较差异有统计学意义(P<0.05);观察组Ⅲ度以上胃肠道反应发生率为8.1%(7/86),对照组为19.5%(16/82),两组比较差异有统计学意义(P<0.05);观察组放疗完成时间(54.72±4.76)d,对照组(61.12±6.71)d,两组比较差异有统计学意义(P<0.05)。结论宫颈鳞癌同步放化疗中周疗较3周疗法疗效不良反应更少,疗效相当。 Objective To evaluate the clinical efficacy and safety of chemotherapy weekly in the chemoradiotherapy of cervical cancer.Methods Between Jan 2003 and Oct 2007,168 patients with stage ⅢB squamous cell carcinoma of the uterine cervix in Chongqing Cancer Hospital were divided into two groups randomly.The observation group,total 86 patients receiving radiotherapy concomitant with weekly cisplatin and taxol;the matched group,total 82 patients,receiving radiotherapy concomitant with cisplatin plus taxol every 3weeks.There were no statistical difference in the clinical and pathological characteristics between the two groups.We compare the 5years survival rate and side reaction of the two groups.Results The 5years survival rate of the observation group and the matched group were respectively 52.3%(45/86)and 42.7%(35/82),in which there was no significant difference(P〈0.05).The response rate(CR+PR)were respectively 94.2%(81/86)and 92.7%(76/82)in the observation group and the matched group,in which there was no significant difference(P〈0.05).GradeⅢ acute gastrointestinal toxicities(nausea and vomiting)in the matched group were exactly higher than that in the observation group [19.5%(16/82)vs.8.1%(7/86),P〉0.05].Moreover,GradeⅢ myelosuppression in the matched group were exactly higher than that in the observation group[20.7%(17/82)vs.9.3%(8/86),P〉0.05].there were no significant difference of the incidence of the radiocystitis,radiation proctitis and radiodermatitis between the two groups.But the Radiotherapy completion time in the matched group were exactly longer than that in the observation group[(61.12±6.71)days vs.(54.72±4.76)days,P〈0.05].Conclusion The toxicity of the observation group was lower than the matched group.Moreover the efficacy of observation group is similar to the matched group.
出处 《重庆医学》 CAS 北大核心 2015年第6期801-803,共3页 Chongqing medicine
关键词 子宫颈肿瘤 同步放化疗 顺铂 uterine cervical neoplasms chemoradiotherapy cisplatin
  • 相关文献

参考文献4

二级参考文献28

  • 1管忠震,徐瑞华.奈达铂临床研究进展[J].中国肿瘤临床,2004,31(13):774-780. 被引量:176
  • 2连丽娟,刘彤华,刘炽明,等.林巧雅妇科肿瘤学.第2版.北京:人民卫生出版社,1994.
  • 3古铣之,殷蔚伯.治疗放射肿瘤学.北京:中国协和医科大学出版社,2002.
  • 4蔡树模 王香娥 王琪.子宫颈癌的高剂量后装治疗[J].中国放射肿瘤学,1988,(1).
  • 5Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiatoin and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Eng J Med, 1999, 340: 1154-1161.
  • 6Whitney CW, Sause W, Bundy BN, et al. A randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stages Ⅱ B-Ⅳ A carcinoma of the cervix with negative para-aortic lymph nodes: a gynecologic oncology group and southwest oncology group study. J Clin Oncol, 1999, 17:1339-1348.
  • 7Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Eng J Med, 1999, 340:1144-1153.
  • 8Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for highrisk cervical cancer. N Eng J Med, 1999, 340: 1137-1143.
  • 9Peters WA, Liu PY, Barrett RJ, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clincal Oncol, 2000, 18:1606-1613.
  • 10Lehman M, Thomas G. Is concurrent chemotherapy and radiotherapy the new standard of care for locally advanced cervical cancer? Int J Gynecol Cancer, 2001, 11:87-99.

共引文献29

同被引文献70

引证文献5

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部